Gene Query: NHSL2

Dataset Description Geneva Score
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 55.59
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 48.41
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 45.38
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 40.26
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 38.06
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 36.18
The MEF2B Regulatory Network 36.04
The MEF2B Regulatory Network - RNA-seq data 36.04
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 35.32
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 34.55
Investigation about fibroblasts of different origins in culture 33.02
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 32.28
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 32.28
Intron retention induced by microsatellite expansions as a disease biomarker. 32.25
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 31.65
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 31.03
Targeting EZH2 in MYCN-amplified Neuroblastoma 30.36
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 30.36
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 28.72
Transcriptomic analyssis following EHMT1/2 inhibition 28.05
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 27.68
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 26.23
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 25.78
LncRNA expression profiling of ischemic stroke patients 22.9
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 21.85
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 21.56
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 21.23
Characterization of human ILC2 subsets 20.83
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 20.24
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 20.07
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 20.05
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 20.03
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 19.99
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 19.7
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 19.7
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 19.56
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 19.34
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 18.99
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 18.98
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 18.94
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 18.88
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 18.88
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 18.7
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 18.33
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 18.25
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 18.23
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 18.23
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 18.17
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 18.17
naive T cell heterogeneity after neonatal thymectomy 17.72
ZIKV infection of monocytes activates inflammasome pathways 17.42
Transcriptome of Stabilin-1 siRNA transfected human monocytes 17.04
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 16.55
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 16.49
Effect of from Human Umbilical Vein Endothelial Cells 16.24
Tyrosine Kinase Inhibitor Cardiotoxicity 16.22
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 16.22
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 15.93
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 15.77
Molecular Mechanisms of Endothelial Hyperpermeability 15.54
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 15.5
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 15.44
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 15.4
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 15.38
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 15.28
Effects of rFVIIIFc on human macrophages 15.25
An integrative analysis of non-coding regulatory DNA variations associated with autism 15.23
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 14.65
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 14.55
Gene expression signatures of innate lymphoid cells from human blood 14.5
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 14.33
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 14.27
RNA Seq of HMVEC under hypoxia 14.27
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 14.21
Selective suppression of endothelial cytokine production by progesterone receptor 14.16
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 14.16
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 14.1
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 14.1
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 14.07
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 14.07
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 13.97
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 13.8
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 13.76
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 13.41
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 13.29
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 13.14
Human neutrophil genome during PMA- and E. coli encounter-induced activation 13.14
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 13.0
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 12.87
The Genomic Landscape of Atypical Fibroxanthoma 12.64
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 12.4
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 12.28
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 11.94
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.89
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 11.71
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 11.71
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 11.51
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 11.51
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 11.51
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 11.44
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 11.31
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 11.23
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 11.13
RNA sequencing with KSHV infection and enrichment for circular RNAs 11.04
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 10.97
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 10.91
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.68
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 10.55
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 10.55
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 10.41
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 10.15
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 10.05
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 9.96
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 9.76
Aging-associated patterns in the expression of human endogenous retroviruses 9.59
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 9.47
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 9.47
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 9.39
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 9.35
Controlling for gene expression changes in transcription factor protein networks. 9.29
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 9.23
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 9.05
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 9.05
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 9.04
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 9.01
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 9.01
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 8.97
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 8.97
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 8.97
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 8.89
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 8.89
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 8.87
Tpl-2 small molecule project 8.84
Tpl-2 and MEK small molecule inhibitors 8.84
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 8.59
Transcriptional profile in human S. haematobium infection 8.59
RNA sequencing of BT142 and TS603 cell lines 8.58
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 8.58
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 8.58
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 8.54
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 8.49
miRNAs affected by antagomiR-17 treatment 8.47
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 8.31
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 8.3
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 8.14
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 8.05
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 7.97
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 7.91
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 7.91
Expression profiles of the four human major ectodermal lineages 7.89
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 7.83
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 7.79
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 7.79
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 7.63
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 7.56
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.52
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 7.51
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 7.4
Zika virus directly infects human peripheral neurons and induces cell death 7.35
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 7.2
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.18
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 7.16
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 7.16
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 7.12
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 7.04
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 7.01
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.98
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 6.97
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.94
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.94
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 6.92
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 6.9
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 6.89
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 6.89
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 6.89
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 6.84
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 6.82
Dysregulated immune system networks in war veterans with PTSD 6.81
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 6.79
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 6.79
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 6.79
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 6.78
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 6.66
Next Generation Sequencing of human SMA and healthy control Motor Neurons 6.63
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 6.58
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 6.57
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 6.55
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 6.55
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 6.54
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 6.54
Zika infected neural stem cells 6.52
Transcriptome analysis of Zika infected neural stem cells 6.52
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 6.51
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 6.42
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 6.41
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 6.41
Inhibition of TNBC metastasis by Gpx1 6.4
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 6.37
High level DNA repair gene expression in human ES cells 6.33
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 6.33
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 6.28
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 6.28
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.19
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.19
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 6.19
RNA-sequencing of human tendon after injury 6.18
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 6.03
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 5.93
Transcriptomic profiling of human peripheral blood-derived mast cells 5.93
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 5.82
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 5.74
RNA expression analysis upon JMJD1C depletion 5.67
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.67
Role of FGFR1 in neuronal devlopment 5.67
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 5.64
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 5.61
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 5.55
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 5.52
Fibroblasts in cholesteatoma activate osteoclasts. 5.52
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 5.5
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 5.47
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 5.47
CDK12 mediated transcriptional regulation in U2OS cells 5.45
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 5.44
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 5.42
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 5.39
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 5.38
Exploring the RNA landscape of endothelial exosomes 5.37
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 5.36
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 5.35
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 5.28
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.28
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 5.28
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 5.23
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 5.22
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.21
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 5.14
mRNA expression profile of Lymphocytes by high-throuput sequencing 5.12
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 5.11
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 5.06
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 5.05
The pioneer factor CEBPA modulates vitamin D signaling 5.05
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.04
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 5.04
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.02
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 5.02
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 5.0
The expression profiles of GBC liver metastasis 4.96
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 4.95
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.94
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 4.93
Age-Related Gene Expression Changes in Prostate Cancer Patients 4.93
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.92
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 4.92
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 4.86
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.84
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 4.83
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 4.82
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.82
Endothelial gene expression analysis 4.81
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.81
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 4.8
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 4.78
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 4.76
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 4.76
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 4.76
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 4.67
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 4.66
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 4.65
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.64
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 4.64
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 4.64
A map of gene expression in neutrophil-like cell lines 4.64
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 4.59
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.59
RNA-seq of naive and primed ES cells (NHSM) 4.57
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 4.57
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 4.56
Gene expression profile of human iPSC-derived nephron progenitor cells 4.55
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 4.49
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 4.46
Transcriptome analysis of peripheral blood monocytes 4.45
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.38
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.38
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 4.37
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 4.37
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 4.3
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.23
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.23
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.23
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 4.22
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 4.19
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.11
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 4.07
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 4.06
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 4.0
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 4.0
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 3.97
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 3.96
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 3.95
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 3.9
PGE2 mediated gene expression changes in human cervical stromal cells 3.9
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 3.89
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.88
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.83
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 3.72
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 3.71
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 3.71
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.69
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 3.69
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 3.68
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 3.68
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 3.66
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 3.66
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 3.64
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.63
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.63
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.58
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.57
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.57
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 3.57
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.55
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.55
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 3.52
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.52
mRNA expression profile of Lymphocytes 3.51
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 3.51
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.5
miR-93 Targets in Human Endothelial Cells 3.5
Dermal endothelial cells of type 2 diabetic patients 3.49
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 3.45
The gene expression profiles of gallbladder cancer 3.45
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.3
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 3.25
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 3.2
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 3.2
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.18
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.12
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 3.1
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 3.1
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 3.09
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 3.09
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 3.06
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 3.02
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 3.02
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.96
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.94
Unique features and clinical importance of acute alloreactive immune responses 2.92
Global transcriptome analysis of WT versus HEB-/- hESCs 2.81
PNET animal model: new insights (II) 2.81
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 2.74
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 2.74
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 2.71
Trascriptome of thyroid cancer-induced macrophages 2.71
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.7
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 2.68
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 2.68
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 2.67
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.67
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 2.64
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.64
HEK293 Heat-shock experiment 2.58
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.58
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.57
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.54
RNA-seq of stable and unstable section of human atherosclerotic plaques 2.52
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 2.5
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 2.46
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.45
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.44
RNA-seq melanoma 2.44
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 2.43
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 2.43
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.42
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.39
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 2.37
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 2.37
RNAseq of Breast cancer PDX samples 2.28
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 2.27
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 2.26
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 2.23
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.21
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 2.19
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 2.14
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.13
RNA-Seq and expression data from human adipose tissue 2.13
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.13
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.12
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 2.09
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.09
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.09
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 2.07
The role of CFTR in islet function 2.04
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.03
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.03
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.03
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.02
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.96
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.94
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.91
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 1.89
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.85
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 1.84
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.83
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.82
Leucegene: ALL sequencing 1.8
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.78
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.75
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.68
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.68
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.64
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.6
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.59
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.58
Reprogrammed myeloid cell transcriptomes in NSCLC 1.57
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.57
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.54
TAF1 is critical for AE driven leukemogenesis 1.54
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.51
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.51
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.47
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.45
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.42
iPSC-Derived Cholangiocytes 1.39
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.32
Leucegene: AML sequencing (part 6) 1.29
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 1.27
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.27
Genome-wide Analysis of Chromatin Interactions in Human Cells 1.23
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.22
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.22
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.19
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.16
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.16
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.15
Transcriptomes in healthy and CHB fetal hearts 1.14
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 1.11
BMS-470539 on human synovial fibroblasts 1.1
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 1.04
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.04
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.02
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.99
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 0.97
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 0.97
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 0.97
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.97
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 0.95
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.94
Epigenomic conservation of transposable element silencing 0.92
Epigenomic conservation of transposable element silencing [RNA-seq] 0.92
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.89
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 0.89
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.87
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.87
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.85
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.79
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.78
Expression analysis of the TAF1 syndrome 0.75
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.74
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.71
Identification of renal resident macrophages across species [C1] 0.7
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.7
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.69
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.69
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 0.67
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.67
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.65
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.64
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.61
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.6
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 0.6
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.58
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.58
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.57
Gene expression profile of CRC-derived HILEC 0.57
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.55
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.5
Identification of renal resident macrophages across species 0.47
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.44
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.44
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.41
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.41
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.38
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.38
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.38
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.38
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.38
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 0.34
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.34
The contribution of Alu exons to the human proteome 0.31
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.3
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.29
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 0.29
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.29
Transcriptome of activated human and mouse MAIT cells 0.22
EGR1-controlled transcriptome of T HESCs 0.18
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.15
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.15
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.07
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation